Holy Hormones Honey! What we do know is that IUDs cause a ‘mild’ infection in the uterus. Coupled with that today’s IUDss are dripping synthetic hormones into the body in addition to the mild infection. Add in a nutrient depleted hormonally imbalanced body – an at risk immune system – and to me that spells risk of PID.
The authors of the study made this comment:
Although the risk of PID in IUD users is highest in the first 20 days after insertion, 90 days after insertion was chosen as the benchmark in order to be conservative in estimating the risk of PID.
What happens in 91 days, 100 days or 120 days? Does that not count? The longer a woman has this IUD in – the longer the mild infection, the more compromised the immune system for having to continuously having to fight the infection. In addition the synthetic hormones deplete nutrients in the body and will throw off the body’s natural production of hormones. Still spell the potential for the development of PID to me.
Especially if a woman’s health is compromised to begin with.
Note the backers of the study are a huge insurance conglomerate who stand to make millions of dollars from pharma off this device. Oh, did any of you think they had your well being in mind? Might as well through the American College of Obstetrics and Gynecology (ACOG) into this (what appears to be) collusion… since they are the ones who recommended the IUD for teen girls.
IUDs Don’t Cause Pelvic Inflammatory Disease in Women, Experts Say
November 20, 2012
The risk of developing pelvic inflammatory disease (PID) following insertion of an intrauterine device (IUD) is very low, whether or not women have been screened beforehand for gonorrhea and chlamydia, according to a joint study of nearly 60,000 women by researchers at the University of California, San Francisco (UCSF), and Kaiser Permanente Northern California Division of Research.
The study appears this week in the current online issue of Obstetrics & Gynecology, the official journal of the American College of Obstetricians and Gynecologists, also known as Green Journal.
The findings correct long-standing misperceptions that IUDs cause PID. Also, by evaluating the relationship between the timing of testing for gonorrhea and chlamydia (GC/CT) and the risk of developing PID within 90 days after IUD insertion, the study fills a large gap in the evidence base for the optimal timing and necessity of testing women who have no symptoms of gonorrhea and chlamydia.
Because gonorrhea or chlamydia infection is a risk factor for PID in any woman, there is a concern that inserting an IUD in someone who has an asymptomatic infection could increase that risk of PID. This study shows that protocols that test on the same day as IUD insertion, and then promptly treat women who test positive, do not increase the risk of developing PID compared to women who were screened ahead of time or not at all.
“This study affirms that there is a low risk of pelvic inflammatory disease after IUD insertion, which has the potential to reduce barriers to IUD access, such as making women have a separate screening visit before the IUD insertion,” said lead author Carolyn B. Sufrin, MD, MA, of UCSF’s Bixby Center for Global Reproductive Health.
“In addition, it provides evidence to support [Centers for Disease Control and Prevention] screening guidelines for gonorrhea and chlamydia in women receiving IUDs. If testing is indicated, our results suggest that it is safe to do so on the day of IUD insertion, with prompt treatment of positive results,” said Debbie Postlethwaite, RNP, MPH with the Kaiser Permanente Division of Research in Oakland, Calif.
The researchers explained that the most accurate time to clinically assess and screen for cervical infection is on the day of IUD insertion. They also emphasized that a woman’s risk status does not depend on her method of contraception, or when she is screened, but rather on sexual behaviors. Women with high-risk sexual behaviors continue to be at increased risk of GC/CT acquisition even after IUD placement, they said.